Increased paxlovid use could lead to significant hospitalization reductions and cost savings : vimarsana.com

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

Related Keywords

Texas , United States , Lin Wang , Hainan , China , Hong Kong , Kobe , Hyogo , Japan , University Of Hong Kong , Hong Kong General , Cambridge , Cambridgeshire , United Kingdom , Alisonp Galvani , Lauren Ancel Meyers , Petter Holme , Erichy Lau , Robertm Krug , Isaac Chun Hai Fung , Benjaminj Cowling , Ut Department Of Molecular Biosciences , Kobe University , Health Bureau , Us National Institutes Of Health , National Institutes Of Health , National Natural Science Foundation Of China , Research Fund , Georgia Southern University , Aalto University , Yale School Of Public Health , Centers For Disease , University Of Texas At Austin , University Of Cambridge , Emerging Infectious , Ancel Meyers , Pandemic Decision Science , Yale School , Public Health , Molecular Biosciences , Technology Commission , Special Administrative Region , Disease Control , Medical Research Fund , National Natural Science Foundation , Antiviral Drug , Ovid 19 , Pidemiology , Nfectious Diseases , Micron , Ublic Health , Esearch , Irus ,